ArticleTherapeutic advances in medical oncology2025

Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort.

Małgorzata Pienia̧żek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.